Rajat Bannerji, MD, PhD¹, John N. Allan, MD², Jon E. Arnason, MD³, Jennifer R. Brown, MD, PhD^4*, Ranjana Advani, MD⁵, Stephen M. Ansell, MD, PhD⁶, Susan M. O'Brien, MD⁷, Johannes Duell, MD^8*, Peter Martin, FRCPC, MD, MS², Robin M. Joyce, MD⁹, Jingjin Li, PhD^10*, Dina M. Flink, PhD^10*, Min Zhu, PhD^10*, David M. Weinreich, MD^10*, George D. Yancopoulos, MD, PhD^10*, Andres Sirulnik, MD, PhD¹⁰, Aafia Chaudhry, MD, MBA, MS^10*, Srikanth R. Ambati, MBBS, MD^10* and Max S. Topp, MD⁸

¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²Weill Cornell Medicine, New York, NY
³Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Stanford University, Stanford, CA
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
⁸Universitätsklinikum Würzburg, Würzburg, Germany
⁹Beth Israel Deaconess Medical Center, Boston, MA
¹⁰Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Adam J Olszewski, MD¹, Abraham Avigdor, MD^2,3, Sunil Babu^4*, Itai Levi, MD^5*, Uri Abadi^2,6*, Houston Holmes^7*, Matthew McKinney⁸, Ron McCord^9*, Yuying Xie^10*, Cindy Chen^9*, Kati Sarouei^9*, Naseer Qayum^11*, Carol O’Hear^9*, Gila Sellam^12* and Herbert Eradat¹³

¹Brown University, Providence, RI
²Tel Aviv University, Tel Aviv, Israel
³Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
⁴Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN
⁵Soroka University Medical Center, Be'er-Sheva, Israel
⁶Meir Medical Center, Kfar Saba, Israel
⁷Texas Oncology, Dallas, TX
⁸Duke Cancer Institute, Durham, NC
⁹Genentech, Inc., South San Francisco, CA
¹⁰F. Hoffmann-La Roche Ltd, Mississauga, Canada
¹¹F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom
¹²F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹³University of California, Los Angeles, CA

Martin Hutchings, MD, PhD^1*, Rogier Mous, MD, PhD^2*, Michael Roost Clausen, MD, PhD^3*, Peter Johnson, MD, FRCP⁴, Kim M Linton^5*, Martine E.D. Chamuleau, MD, PhD⁶, David John Lewis, MD^7*, Anna Sureda Balari, MD, PhD^8*, David Cunningham, MD, FRCP, FMedSci^9*, Roberto S Oliveri, MD, PhD^10*, Dena DeMarco^11*, Brian Elliott, MD¹¹, Kuo-mei Chen, PhD^11* and Pieternella J. Lugtenburg, MD, PhD¹²

¹Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
²on behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
³Vejle Hospital, Vejle, Denmark
⁴Cancer Research UK, Cancer Services, University of Southampton, Southampton, United Kingdom
⁵Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
⁶on behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, VU University Medical Center, Amsterdam, Netherlands
⁷Plymouth University Medical School, Plymouth, United Kingdom
⁸Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
⁹The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
¹⁰Genmab A/S, Copenhagen, Denmark
¹¹Genmab, Princeton, NJ
¹²Erasmus MC Cancer Institute, department of Hematology, Rotterdam, Netherlands

Martin Hutchings, MD, PhD^1*, Carmelo Carlo-Stella, MD², Emmanuel Bachy, MD, PhD^3*, Fritz Offner, MD, PhD⁴, Franck Morschhauser, MD, PhD^5*, Michael Crump⁶, Gloria Iacoboni, MD^7*, Anna Sureda Balari, MD, PhD^8*, Joaquin Martinez-Lopez, MD^9*, Linda Lundberg^10*, Mark Dixon^11*, David Perez Callejo^10*, James Relf^11*, David Carlile^11*, Emily Piccione^12*, Kathryn Humphrey^11* and Michael Dickinson, MBBS, FRACP, FRCPA¹³

¹Rigshospitalet, Copenhagen, Denmark
²Humanitas Clinical and Research Center, and Humanitas University, Milan, Italy
³Hospices Civils De Lyon and Université Claude Bernard, Pierre-Bénite, France
⁴Universitair Ziekenhuis Gent, Ghent, Belgium
⁵Hôpital Claude Huriez and Centre Hospitalier Régional Universitaire de Lille, Lille, France
⁶Princess Margaret Hospital, Toronto, ON, Canada
⁷Vall d’Hebron University Hospital, Barcelona, Spain
⁸Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
⁹Hospital Universitario 12 de Octubre (H12O), Centro Nacional de Investigaciones Oncológicas (CNIO)-H12O and Universidad Complutense de Madrid, Madrid, Spain
¹⁰F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹¹Roche Products Ltd, Welwyn Garden City, United Kingdom
¹²Genentech, Inc., South San Francisco, CA
¹³Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia

Peter Borchmann¹, Anja Jühling^1*, Philipp Gödel^1*, Hyatt Balke-Want^1*, Christoph Schmid^2*, Francis A. Ayuk^3*, Silke Holtkamp^4*, Liane Preussner^4*, Gregor Zadoyan^4*, Linda Hanssens^4*, Andrew Kaiser^5*, Marion Jurk^5*, Iris Bürger^5*, Dina Schneider^6*, Boro Dropulic^6*, Toon Overstijns^4,5*, Christof Scheid, MD⁷, Udo Holtick^8*, Stefan Miltenyi^4,5,6* and Michael Hallek^1,8

¹Department of Internal Medicine I, Cologne Lymphoma Working Group, University Hospital of Cologne, Cologne, Germany
²II. Med. Klinik Hämatologie/Onkologie, Universitäts-Klinikum Augsburg, Augsburg, Germany
³UKE Hamburg-Eppendorf, Hamburg, Germany
⁴Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany
⁵Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
⁶Lentigen Technology Inc., A Miltenyi Company, Gaithersburg, MD
⁷Department of Internal Medicine I, Leukapheresis and Stem Cell Transplant Unit, University of Cologne, Cologne, Germany
⁸Department of Internal Medicine I, Leukapheresis and Stem Cell Transplant Unit, University Hospital of Cologne, Cologne, Germany

Sattva S. Neelapu, MD¹, Michael Dickinson, MBBS, FRACP, FRCPA², Matthew L. Ulrickson, MD³, Olalekan O. Oluwole, MBBS, MPH⁴, Alex F. Herrera, MD⁵, Catherine Thieblemont, MD, PhD⁶, Chaitra S. Ujjani, MD⁷, Yi Lin, MD, PhD⁸, Peter A. Riedell, MD^9*, Natasha Kekre, MD, MPH, FRCPC¹⁰, Sven de Vos, MD, PhD¹¹, Yin Yang, MS^12*, Francesca Milletti, PhD^12*, Lovely Goyal, PhD^12*, Jun Kawashima, MD^12* and Julio C. Chavez, MD¹³

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Peter MacCallum Cancer Centre and University of Melbourne, East Melbourne, VIC, Australia
³Banner MD Anderson Cancer Center, Gilbert, AZ
⁴Vanderbilt-Ingram Cancer Center, Nashville, TN
⁵City of Hope National Medical Center, Duarte, CA
⁶Hospital Saint-Louis, Paris, France
⁷Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA
⁸Mayo Clinic, Rochester, MN
⁹University of Chicago Medicine, Chicago, IL
¹⁰The Ottawa Hospital, Ottawa, ON, Canada
¹¹David Geffen School of Medicine at UCLA, Santa Monica, CA
¹²Kite, a Gilead Company, Santa Monica, CA
¹³Moffitt Cancer Center, Tampa, FL